IBDEI206 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,31962,2)
 ;;=^270477
 ;;^UTILITY(U,$J,358.3,31963,0)
 ;;=N90.0^^126^1637^13
 ;;^UTILITY(U,$J,358.3,31963,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31963,1,3,0)
 ;;=3^VIN 1
 ;;^UTILITY(U,$J,358.3,31963,1,4,0)
 ;;=4^N90.0
 ;;^UTILITY(U,$J,358.3,31963,2)
 ;;=^5015891
 ;;^UTILITY(U,$J,358.3,31964,0)
 ;;=N90.1^^126^1637^14
 ;;^UTILITY(U,$J,358.3,31964,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31964,1,3,0)
 ;;=3^VIN 2
 ;;^UTILITY(U,$J,358.3,31964,1,4,0)
 ;;=4^N90.1
 ;;^UTILITY(U,$J,358.3,31964,2)
 ;;=^5015892
 ;;^UTILITY(U,$J,358.3,31965,0)
 ;;=D07.1^^126^1637^15
 ;;^UTILITY(U,$J,358.3,31965,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31965,1,3,0)
 ;;=3^VIN 3
 ;;^UTILITY(U,$J,358.3,31965,1,4,0)
 ;;=4^D07.1
 ;;^UTILITY(U,$J,358.3,31965,2)
 ;;=^5001943
 ;;^UTILITY(U,$J,358.3,31966,0)
 ;;=Z90.710^^126^1638^2
 ;;^UTILITY(U,$J,358.3,31966,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31966,1,3,0)
 ;;=3^Acquired Absense of Cervix & Uterus
 ;;^UTILITY(U,$J,358.3,31966,1,4,0)
 ;;=4^Z90.710
 ;;^UTILITY(U,$J,358.3,31966,2)
 ;;=^5063591
 ;;^UTILITY(U,$J,358.3,31967,0)
 ;;=Z90.711^^126^1638^1
 ;;^UTILITY(U,$J,358.3,31967,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31967,1,3,0)
 ;;=3^Acquired Absence of Uterus w/ Remaining Cervical Stump
 ;;^UTILITY(U,$J,358.3,31967,1,4,0)
 ;;=4^Z90.711
 ;;^UTILITY(U,$J,358.3,31967,2)
 ;;=^5063592
 ;;^UTILITY(U,$J,358.3,31968,0)
 ;;=N80.0^^126^1638^3
 ;;^UTILITY(U,$J,358.3,31968,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31968,1,3,0)
 ;;=3^Adenomyosis
 ;;^UTILITY(U,$J,358.3,31968,1,4,0)
 ;;=4^N80.0
 ;;^UTILITY(U,$J,358.3,31968,2)
 ;;=^270482
 ;;^UTILITY(U,$J,358.3,31969,0)
 ;;=N85.6^^126^1638^4
 ;;^UTILITY(U,$J,358.3,31969,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31969,1,3,0)
 ;;=3^Asherman's Syndrome
 ;;^UTILITY(U,$J,358.3,31969,1,4,0)
 ;;=4^N85.6
 ;;^UTILITY(U,$J,358.3,31969,2)
 ;;=^270523
 ;;^UTILITY(U,$J,358.3,31970,0)
 ;;=C54.1^^126^1638^5
 ;;^UTILITY(U,$J,358.3,31970,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31970,1,3,0)
 ;;=3^CA,Endometrium
 ;;^UTILITY(U,$J,358.3,31970,1,4,0)
 ;;=4^C54.1
 ;;^UTILITY(U,$J,358.3,31970,2)
 ;;=^5001206
 ;;^UTILITY(U,$J,358.3,31971,0)
 ;;=C54.3^^126^1638^6
 ;;^UTILITY(U,$J,358.3,31971,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31971,1,3,0)
 ;;=3^CA,Fundus Uteri
 ;;^UTILITY(U,$J,358.3,31971,1,4,0)
 ;;=4^C54.3
 ;;^UTILITY(U,$J,358.3,31971,2)
 ;;=^5001208
 ;;^UTILITY(U,$J,358.3,31972,0)
 ;;=C54.2^^126^1638^7
 ;;^UTILITY(U,$J,358.3,31972,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31972,1,3,0)
 ;;=3^CA,Myometrium
 ;;^UTILITY(U,$J,358.3,31972,1,4,0)
 ;;=4^C54.2
 ;;^UTILITY(U,$J,358.3,31972,2)
 ;;=^5001207
 ;;^UTILITY(U,$J,358.3,31973,0)
 ;;=C54.8^^126^1638^8
 ;;^UTILITY(U,$J,358.3,31973,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31973,1,3,0)
 ;;=3^CA,Overlapping Sites of Uterus
 ;;^UTILITY(U,$J,358.3,31973,1,4,0)
 ;;=4^C54.8
 ;;^UTILITY(U,$J,358.3,31973,2)
 ;;=^5001209
 ;;^UTILITY(U,$J,358.3,31974,0)
 ;;=C54.9^^126^1638^9
 ;;^UTILITY(U,$J,358.3,31974,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31974,1,3,0)
 ;;=3^CA,Uterus,Unspec Site
 ;;^UTILITY(U,$J,358.3,31974,1,4,0)
 ;;=4^C54.9
 ;;^UTILITY(U,$J,358.3,31974,2)
 ;;=^5001210
 ;;^UTILITY(U,$J,358.3,31975,0)
 ;;=N85.02^^126^1638^10
 ;;^UTILITY(U,$J,358.3,31975,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31975,1,3,0)
 ;;=3^Endomet Hyperpla w/ Atyp
 ;;^UTILITY(U,$J,358.3,31975,1,4,0)
 ;;=4^N85.02
